These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7957629)

  • 41. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
    Kreiss DS; Lucki I
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1268-79. PubMed ID: 8014870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pre- and post-synaptic effects of the 5-HT3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain.
    Haddjeri N; Blier P
    Synapse; 1995 May; 20(1):54-67. PubMed ID: 7624830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists.
    Cox RF; Meller E; Waszczak BL
    Synapse; 1993 Aug; 14(4):297-304. PubMed ID: 8248853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.
    Lejeune F; Millan MJ
    Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function.
    Garratt JC; Crespi F; Mason R; Marsden CA
    Eur J Pharmacol; 1991 Jan; 193(1):87-93. PubMed ID: 1710990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of putative 5-HT1A receptor antagonists on 8-OH-DPAT-induced hypothermia in rats and mice.
    Moser PC
    Eur J Pharmacol; 1991 Feb; 193(2):165-72. PubMed ID: 1828767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists.
    Sprouse JS; Aghajanian GK
    Eur J Pharmacol; 1986 Sep; 128(3):295-8. PubMed ID: 2878817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus.
    Romero L; Celada P; Artigas F
    Eur J Pharmacol; 1994 Nov; 265(1-2):103-6. PubMed ID: 7883021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis.
    Cervo L; Grignaschi G; Samanin R
    Eur J Pharmacol; 1988 Dec; 158(1-2):53-9. PubMed ID: 2975608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
    Forster EA; Cliffe IA; Bill DJ; Dover GM; Jones D; Reilly Y; Fletcher A
    Eur J Pharmacol; 1995 Jul; 281(1):81-8. PubMed ID: 8566121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular effects of 5-HT1A receptor agonists injected into the dorsal raphe nucleus of conscious rats.
    Connor HE; Higgins GA
    Eur J Pharmacol; 1990 Jun; 182(1):63-72. PubMed ID: 2144824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blockade of transmission at NMDA receptors facilitates the electrical and synthetic activity of ascending serotoninergic neurones.
    Lejeune F; Gobert A; Rivet JM; Millan MJ
    Brain Res; 1994 Sep; 656(2):427-31. PubMed ID: 7820605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
    Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG
    Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.
    Laporte AM; Schechter LE; Bolaños FJ; Vergé D; Hamon M; Gozlan H
    Eur J Pharmacol; 1991 May; 198(1):59-67. PubMed ID: 1680714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
    Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K
    Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.